6th IAS Conference On HIV Pathogenesis, Treatment and Prevention

The Cutting Edge: What's New in Male Circumcision SUSA14

Organiser: Jhpiego
Non-Commercial Satellite Back
Venue: MR 1
Time: 17:00 - 19:00, 17.07.2011
Code: SUSA14
Chair: Kelly Curran, United States

For more than 35 years, Jhpiego has pioneered innovative, low-cost, lifesaving solutions for today's global health concerns, including the prevention of HIV/AIDS.  One of the most effective tools that exists today is voluntary medical male circumcision (VMMC).

Compelling evidence indicates that VMMC can reduce the risk of female-to-male transmission of HIV by approximately 60%.  VMMC provides a greater protective benefit than any potential vaccine studied to date. Modeling suggests that rapid scale up of VMMC to 80% of adult males in East and Southern Africa would avert more than 3 million new infections and save 416.5 billion in care and treatment costs by 2025. Further, there is evidence that female partners of circumcised men have lower rates of cervical cancer and certain sexually transmitted infections.

Join Jhpiego and its partners from WHO, UNAIDS and the Kenya Ministry of Health for conversation and refreshments. 

Presentations in this session:


Presented by Kelly Curran, United States

DVD presentation


2007-2011: State of the VMMC scale up
Presented by Catherine Hankins, Switzerland

Start at the beginning: early infant MC
Presented by Tigistu Adamu, United States


Adult MC device update and WHO approval process for medical devices
Presented by Tim Farley, Switzerland

250,000 circumcisions in 2.5 years
Presented by Peter Cherutich, Kenya

Matching supply with demand for VMMC
Presented by Hally R Mahler, Tanzania, United Republic of

Powerpoints presentations

2007-2011: State of the VMMC scale up - Catherine Hankins

Adult MC device update and WHO approval process for medical devices - Tim Farley


    The organizers reserve the right to amend the programme.

Contact Us | Site map © 2011 International AIDS Society